We previously conducted a primary observational study to investigate the effect of immunoadsorption (IA) in patients with infection-triggered ME/CFS with elevated ADRB2 AABs. Here, ADRB2 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.